CARTHERICS PTY LTD has a total of 18 patent applications. Its first patent ever was published in 2016. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are DEMEGEN INC, VOR BIOPHARMA INC and SERRERO GINETTE.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 4 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | Australia | 2 | |
#4 | Canada | 2 | |
#5 | China | 2 | |
#6 | Singapore | 2 | |
#7 | United States | 2 | |
#8 | Israel | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Therapeutic chemical compounds | |
#3 | Microorganisms | |
#4 | Medical preparations | |
#5 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Trounson Alan | 17 |
#2 | Boyd Richard | 17 |
#3 | Kawamoto Hiroshi | 10 |
#4 | Evtimov Vera | 7 |
#5 | Nisbet Ian | 7 |
#6 | Prince Miles | 6 |
#7 | Shu Runzhe | 3 |
#8 | Hudson Peter John | 2 |
#9 | Boyd Nicholas | 1 |
Publication | Filing date | Title |
---|---|---|
WO2021022327A1 | Immune cells expressing modified cell receptors and methods of making | |
CA3089151A1 | T cell disease treatment targeting tag-72 | |
CN109152824A | Genetically modified cell and application thereof |